New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
07:46 EDTMDRXAllscripts price target lowered to $11 from $16 at RW Baird
Baird lowered its price target on Allscripts following its announcement management has concluded its exploration of strategic alternatives that did not produce a sale or merger of the company. The firm removed the takeout premium and believes investors should view the company as a long term investment with a conservative valuation. Shares remain Outperform rated.
News For MDRX From The Last 14 Days
Check below for free stories on MDRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 20, 2014
07:51 EDTMDRXAllscripts has reached attractive entry point, says RBC Capital
Subscribe for More Information
August 15, 2014
10:20 EDTMDRXAllscripts management to meet with Maxim
Subscribe for More Information
August 14, 2014
07:33 EDTMDRXAllscripts sell-off creates attractive entry point, says Jefferies
Subscribe for More Information
06:35 EDTMDRXAllscripts volatility flat on wide price movement
Allscripts September call option implied volatility is at 32, December is at 33; compared to its 26-week average of 32 according to Track Data, suggesting non-directional price movement.
August 13, 2014
16:11 EDTMDRXAllscripts expands partnership with Clinical Architecture
Subscribe for More Information
August 8, 2014
09:15 EDTMDRXAllscripts profitability poised to expand significantly, says Sterne Agee
Subscribe for More Information
August 7, 2014
16:12 EDTMDRXAllscripts reports Q2 EPS 9c, consensus 9c
Reports Q2 revenue $354M, consensus $352.6M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use